PML update.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D002166:Camptothecin / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000150:complications / Q000188:drug therapy*; D019772:Topotecan
D004791:Enzyme Inhibitors; D019772:Topotecan; D002166:Camptothecin